treatment

Open Access
Disparities in Time to Treatment for Breast Cancer
KULKAEW SUKNIAM, ALI ABBASZADEH KASBI, MOHAMMED ALI ASHARY, KYLE POPP, KRISTOPHER ATTWOOD, ANTHONY GEORGE and EMMANUEL GABRIEL

Anticancer Research December 2022, 42 (12) 5813-5818; DOI: https://doi.org/10.21873/anticanres.16088
You have access
BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC)
MARTIN PESTA, IVAN TRAVNICEK, VLASTIMIL KULDA, JINDRA WINDRICHOVA, HANA REZACKOVA, KATERINA HOUFKOVA, TEREZA MACANOVA, BARBORA BENDOVA, ANDREA NESTOROVA, ONDREJ HES, MILAN HORA, ONDREJ TOPOLCAN and JIRI POLIVKA

Anticancer Research September 2021, 41 (9) 4463-4470; DOI: https://doi.org/10.21873/anticanres.15255
You have access
Multimodal Treatment of Primary Advanced Ovarian Cancer
MICHAEL FRIEDRICH, DOMINIQUE FRIEDRICH, CLAYTON KRAFT and CHRISTOPH ROGMANS

Anticancer Research July 2021, 41 (7) 3253-3260; DOI: https://doi.org/10.21873/anticanres.15111
You have access
Treatment and Other Healthcare Use of Breast Cancer Patients With a Previous Cancer Diagnosis
SAMANTHA MORAIS, ANA RUTE COSTA, LUISA LOPES-CONCEICAO, MARIANA BRANDAO, MARINA BORGES, NATALIA ARAUJO, TERESA DIAS, FILIPA FONTES, SUSANA PEREIRA and NUNO LUNET

Anticancer Research February 2020, 40 (2) 1041-1048; DOI: https://doi.org/10.21873/anticanres.14040
You have access
Which Factors Affect Survival in Patients With Upper Limb Osteosarcoma?
DAVID J. RESTREPO, MARIA T. HUAYLLANI, DANIEL BOCZAR, ANDREA SISTI, AARON C. SPAULDING, RICKEY E. CARTER, STEVEN L. MORAN, ALEXANDER S. PARKER, GALEN PERDIKIS and ANTONIO J. FORTE

Anticancer Research September 2019, 39 (9) 5027-5031; DOI: https://doi.org/10.21873/anticanres.13693
You have access
Novel Therapeutic Approaches for Epstein-Barr Virus Associated Gastric Cancer
BYUNG WOOG KANG, DONG WON BAEK, HYOJEUNG KANG, JIN HO BAEK and JONG GWANG KIM

Anticancer Research August 2019, 39 (8) 4003-4010; DOI: https://doi.org/10.21873/anticanres.13555
You have access
The Role of PEDF in Pancreatic Cancer
DANIEL ANSARI, CARL ALTHINI, HENRIK OHLSSON, MONIKA BAUDEN and ROLAND ANDERSSON

Anticancer Research July 2019, 39 (7) 3311-3315; DOI: https://doi.org/10.21873/anticanres.13473
You have access
The Hippo Signaling Pathway in Pancreatic Cancer
DANIEL ANSARI, HENRIK OHLSSON, CARL ALTHINI, MONIKA BAUDEN, QIMIN ZHOU, DINGYUAN HU and ROLAND ANDERSSON

Anticancer Research July 2019, 39 (7) 3317-3321; DOI: https://doi.org/10.21873/anticanres.13474
You have access
Metastatic Carcinomas of the Adrenal Glands: From Diagnosis to Treatment
ELEFTHERIOS SPARTALIS, IOANNIS DRIKOS, ARGYRIOS IOANNIDIS, DIMOSTHENIS CHRYSIKOS, DIMITRIOS I. ATHANASIADIS, MICHAEL SPARTALIS and DIMITRIOS AVGERINOS

Anticancer Research June 2019, 39 (6) 2699-2710; DOI: https://doi.org/10.21873/anticanres.13395
You have access
Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in “Real-Life” Outside of Clinical Trials
SOTIRIOS SACHANAS, GERASSIMOS A. PANGALIS, ANNA-MARIA FINK, JASMIN BAHLO, KIRSTEN FISCHER, GEORGIA LEVIDOU, MARIE-CHRISTINE KYRTSONIS, VASSILIKI BARTZI, THEODOROS P. VASSILAKOPOULOS, CHRISTINA KALPADAKIS, EFSTATHIOS KOULIERIS, MARIA MOSCHOGIANNIS, XANTHI YIAKOUMIS, PANTELIS TSIRKINIDIS, MARIA K. ANGELOPOULOU, BARBARA EICHHORST and MICHAEL HALLEK

Anticancer Research May 2019, 39 (5) 2591-2598; DOI: https://doi.org/10.21873/anticanres.13382

Main menu

User menu

Search

treatment

Pages